KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 46 filers reported holding KRYSTAL BIOTECH INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $305,000 | +4.1% | 7,079 | 0.0% | 0.18% | +11.9% |
| Q2 2020 | $293,000 | -4.2% | 7,079 | 0.0% | 0.16% | -17.1% |
| Q1 2020 | $306,000 | -21.9% | 7,079 | 0.0% | 0.19% | +21.4% |
| Q4 2019 | $392,000 | +95.0% | 7,079 | +22.1% | 0.16% | +89.3% |
| Q3 2019 | $201,000 | -13.7% | 5,797 | 0.0% | 0.08% | -14.3% |
| Q2 2019 | $233,000 | +92.6% | 5,797 | +57.3% | 0.10% | +104.2% |
| Q1 2019 | $121,000 | +290.3% | 3,686 | +145.4% | 0.05% | +220.0% |
| Q4 2018 | $31,000 | – | 1,502 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |